New drug trial aims to reconnect nerves after spinal injury
Disease control
Recruiting now
This study is testing an investigational drug called NVG-291 to see if it can help improve nerve signaling and function in people with spinal cord injuries. It will involve about 40 people, some with recent injuries and some with injuries from 1-10 years ago. Researchers will mea…
Phase: PHASE1, PHASE2 • Sponsor: NervGen Pharma • Aim: Disease control
Last updated Mar 12, 2026 13:51 UTC